NCT02038868View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

July 22, 2013

Primary Completion Date

April 4, 2014

Study Completion Date

April 4, 2014

Conditions
Benign Prostate Hyperplasia
Interventions
DRUG

ASP4901

oral

DRUG

Tamsulosin

oral

DRUG

Placebo

oral

Trial Locations (2)

Unknown

Kansai

Kanto

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT02038868 - A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia | Biotech Hunter | Biotech Hunter